Walleye Trading
EDIT icon

Walleye Trading’s Editas Medicine EDIT Stock Holding History

Walleye Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,828
Closed -$302K – 4894
2023
Q4 		$302K Buy
+29,828
New +$262K ﹤0.01% 3488
2023
Q3 		– Sell
-3,585
Closed -$29.5K – 5064
2023
Q2 		$29.5K Sell
3,585
-11,841
-77% -$103K ﹤0.01% 4055
2023
Q1 		$112K Sell
15,426
-6,752
-30% -$60K ﹤0.01% 3803
2022
Q4 		$197K Buy
+22,178
New +$243K ﹤0.01% 3585
2022
Q1 		– Sell
-46,327
Closed -$861K – 5453
2021
Q4 		$1.23M Buy
+46,327
New +$1.59M ﹤0.01% 2052
2021
Q3 		– Sell
-27,572
Closed -$1.51M – 5314
2021
Q2 		$1.56M Buy
27,572
+24,846
+911% +$918K 0.01% 1714
2021
Q1 		$114K Sell
2,726
-484
-15% -$27.6K ﹤0.01% 4021
2020
Q4 		$225K Buy
3,210
+369
+13% +$15.2K ﹤0.01% 3416
2020
Q3 		$80K Sell
2,841
-3,718
-57% -$121K ﹤0.01% 3478
2020
Q2 		$194K Sell
6,559
-9,729
-60% -$254K ﹤0.01% 3092
2020
Q1 		$323K Buy
16,288
+5,417
+50% +$137K ﹤0.01% 2225
2019
Q4 		$322K Buy
10,871
+8,791
+423% +$220K ﹤0.01% 2752
2019
Q3 		$47K Buy
2,080
+1,184
+132% +$29.3K ﹤0.01% 3590
2019
Q2 		$22K Buy
+896
New +$21.4K ﹤0.01% 3726
2019
Q1 		– Sell
-32,074
Closed -$726K – 4331
2018
Q4 		$730K Buy
32,074
+28,467
+789% +$775K 0.01% 2074
2018
Q3 		$115K Buy
3,607
+1,141
+46% +$36.9K ﹤0.01% 4134
2018
Q2 		$88K Sell
2,466
-15,259
-86% -$540K ﹤0.01% 4102
2018
Q1 		$588K Buy
+17,725
New +$632K ﹤0.01% 2486

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Trading's EDIT Position: Q1 2024 in Review

Walleye Trading sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 29,828 shares — an estimated $302K sold.

Walleye Trading first reported a position in EDIT in Q1 2018 and held it in 18 quarters. The position peaked at $1.56M in Q2 2021. 226 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Walleye Trading reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 29,828 Editas Medicine shares in Q1 2024, an estimated $302K.
  • Walleye Trading first reported a position in Editas Medicine in Q1 2018 and held it in 18 quarters.
  • Walleye Trading's Editas Medicine position peaked at $1.56M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.